News Conference News AHA 2024 SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity Michael O'Riordan November 16, 2024
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Conference News AHA 2017 Sustained Blood Pressure Reductions With Gastric Bypass Surgery: GATEWAY Michael O'Riordan November 16, 2017